Trials / Unknown
UnknownNCT02140541
The Clinical Profile of UK Asthma Patients With Raised Blood Eosinophils
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 130,248 (actual)
- Sponsor
- Research in Real-Life Ltd · Network
- Sex
- All
- Age
- 12 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To explore the relationship between blood eosinophil counts, asthma exacerbations and patient asthma control using a large primary care based research database
Detailed description
Sputum eosinophil levels have been shown to predict asthma exacerbation and inhaled corticosteroid (ICS) responsivenesss. Managing asthma based on sputum eosinophils leads to fewer exacerbations than management adhering to Global Initiative for Asthma (GINA) guidelines. However the use of sputum to measure eosinophil levels is expensive and impractical within a clinical setting. This study explores the use of blood-eosinophil levels as a clinical predictor for exacerbations and asthma control within a UK primary care dataset.
Conditions
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2014-07-01
- Completion
- 2014-07-01
- First posted
- 2014-05-16
- Last updated
- 2014-05-16
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02140541. Inclusion in this directory is not an endorsement.